Tikun Olam Cannbit Pharmaceuticals Ltd (TA:TKUN) — Market Cap & Net Worth
Market Cap & Net Worth: Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN)
Tikun Olam Cannbit Pharmaceuticals Ltd (TA:TKUN) has a market capitalization of $28.21 Million (ILA10.52 Billion) as of May 8, 2026. Listed on the TA stock exchange, this Israel-based company holds position #23910 globally and #342 in its home market, demonstrating a -7.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tikun Olam Cannbit Pharmaceuticals Ltd's stock price ILA1847.00 by its total outstanding shares 84964515 (84.96 Million). Analyse TKUN cash flow conversion to see how efficiently the company converts income to cash.
Tikun Olam Cannbit Pharmaceuticals Ltd Market Cap History: 2015 to 2026
Tikun Olam Cannbit Pharmaceuticals Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.57 Billion to $420.72 Million (-10.97% CAGR).
Tikun Olam Cannbit Pharmaceuticals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tikun Olam Cannbit Pharmaceuticals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.23x
Tikun Olam Cannbit Pharmaceuticals Ltd's market cap is 0.23 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $110.61 Million | $21.66 Million | -$32.94 Million | 5.11x | N/A |
| 2021 | $60.48 Million | $37.03 Million | -$32.65 Million | 1.63x | N/A |
| 2022 | $21.96 Million | $49.30 Million | -$48.23 Million | 0.45x | N/A |
| 2023 | $7.18 Million | $44.23 Million | -$88.89 Million | 0.16x | N/A |
| 2024 | $7.95 Million | $34.95 Million | -$40.10 Million | 0.23x | N/A |
Competitor Companies of TKUN by Market Capitalization
Companies near Tikun Olam Cannbit Pharmaceuticals Ltd in the global market cap rankings as of May 8, 2026.
Key companies related to Tikun Olam Cannbit Pharmaceuticals Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #501 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #530 globally with a market cap of $50.06 Billion USD ( CN¥342.11 Billion CNY).
- Zoetis Inc (NYSE:ZTS): Ranked #541 globally with a market cap of $49.01 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #574 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #501 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.06 Billion | CN¥53.63 |
| #541 | Zoetis Inc | NYSE:ZTS | $49.01 Billion | $111.22 |
| #574 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $43.83 |
Tikun Olam Cannbit Pharmaceuticals Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Tikun Olam Cannbit Pharmaceuticals Ltd's market cap moved from $1.57 Billion to $ 420.72 Million, with a yearly change of -10.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA420.72 Million | +7693.25% |
| 2025 | ILA5.40 Million | -32.09% |
| 2024 | ILA7.95 Million | +10.79% |
| 2023 | ILA7.18 Million | -67.32% |
| 2022 | ILA21.96 Million | -63.69% |
| 2021 | ILA60.48 Million | -45.33% |
| 2020 | ILA110.61 Million | -47.29% |
| 2019 | ILA209.84 Million | +77.53% |
| 2018 | ILA118.20 Million | +76.56% |
| 2017 | ILA66.95 Million | -93.40% |
| 2016 | ILA1.01 Billion | -35.51% |
| 2015 | ILA1.57 Billion | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Tikun Olam Cannbit Pharmaceuticals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.21 Million USD |
| MoneyControl | $28.21 Million USD |
| MarketWatch | $28.21 Million USD |
| marketcap.company | $28.21 Million USD |
| Reuters | $28.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more